• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.34% Nasdaq Down0.32%

    More On 1093.HK

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    CSPC Pharmaceutical Group Limited (1093.HK)

    -HKSE
    7.60 Down 0.06(0.78%) 3:59AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    CSPC Pharmaceutical Group Limited
    Central Plaza
    32nd Floor
    Wan Chai,
    Hong Kong - Map
    Website: http://www.e-cspc.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:10,565

    Business Summary 

    CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products. It offers finished drugs, including NBP series primarily for the acute ischemic stroke; Oulaining series primarily for the treatment of mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning principally for hypertension; Duomeisu, a chemotherapy drug for the treatment of lymphoma, multiple myeloma, and ovarian and breast cancer; Jinyouli for the prevention of leucopenia and infection induced by chemotherapy; and Ailineng primarily for the treatment of nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion. The company also provides generic drugs, antibiotics, vitamin C products, and caffeine and other drugs; and products, such as benzylpenicillin sodium, ampicillin sodium, cefazolin sodium, cafradin, ceftriaxone, cefotaxime sodium, cefoperazone sodium, amoxicillin capsule, amoxicillin dispersible tablet, amoxicillin granule, etc. In addition, it has 170 products under research and development with focus on the therapeutic areas of cardio-cerebrovascular, diabetes, oncology, neurology, and anti-infective. Further, the company is involved in the provision of pharmaceutical research and development services; sewage and pharmaceutical by-products treatment activities; and trading of pharmaceutical products. It has operations in the People’s Republic of China, other Asian regions, the Americas, Europe, and internationally. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was founded in 1997 and is based in Wan Chai, Hong Kong.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on CSPC Pharmaceutical Group Limited

    Key Executives 
     PayExercised
    Mr. Dongchen Cai , 61
    Exec. Chairman, Chief Exec. Officer, Managing Director and Chairman of Nomination Committee
    4.83MN/A
    Mr. Weidong Pan , 45
    Chief Accountant, Exec. Director and Director of Shijiazhuang Pharmaceutical Group Company Limite
    910.00KN/A
    Mr. Zhenying Feng , 59
    Exec. Director
    912.00KN/A
    Mr. Kin Man Chak , 49
    Exec. Director
    2.30MN/A
    Dr. Shunlong Wang Ph.D., 51
    Exec. Director
    0.00N/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in HKD.